[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Methylmalonic Acidemia (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Methylmalonic Acidemia (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Methylmalonic Acidemia (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Methylmalonic Ac...

April 2021 35 pages

Methylmalonyl CoA Mutase Mitochondrial (Methylmalonyl CoA Isomerase or MCM or MUT or EC 5.4.99.2) - Drugs in Development, 2021

 US$ 3,000.00

Methylmalonyl CoA Mutase Mitochondrial (Methylmalonyl CoA Isomerase or MCM or MUT or EC 5.4.99.2) - Drugs in Development, 2021 SUMMARY Methylmalonyl CoA Mutase Mitochondrial (Methylmalonyl CoA Isomera...

April 2021 30 pages

microRNA 21 (MIR21) - Drugs in Development, 2021

 US$ 3,000.00

microRNA 21 (MIR21) - Drugs in Development, 2021 SUMMARY microRNA 21 (MIR21) - Drugs in Development, 2021 provides in depth analysis on microRNA 21 (MIR21) targeted pipeline therapeutics. The report p...

April 2021 30 pages

Microtubule Associated Protein Tau (Neurofibrillary Tangle Protein or Paired Helical Filament Tau or MAPT) - Drugs in Development, 2021

 US$ 3,000.00

Microtubule Associated Protein Tau (Neurofibrillary Tangle Protein or Paired Helical Filament Tau or MAPT) - Drugs in Development, 2021 SUMMARY Microtubule Associated Protein Tau (Neurofibrillary Tang...

April 2021 150 pages

Middle East Respiratory Syndrome coronavirus S Protein (Spike Protein) - Drugs in Development, 2021

 US$ 3,000.00

Middle East Respiratory Syndrome coronavirus S Protein (Spike Protein) - Drugs in Development, 2021 SUMMARY Middle East Respiratory Syndrome coronavirus S Protein (Spike Protein) - Drugs in Developmen...

April 2021 40 pages

Mitochondrial Diseases (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Mitochondrial Diseases (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Mitochondrial Diseases (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Mitochondrial Di...

April 2021 60 pages

Mitochondrial Myopathy (Musculoskeletal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Mitochondrial Myopathy (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Mitochondrial Myopathy (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Mito...

April 2021 35 pages

Mitogen Activated Protein Kinase Kinase Kinase 14 (NF Kappa Beta Inducing Kinase or Serine/Threonine Protein Kinase NIK or MAP3K14 or EC 2.7.11.25) - Drugs in Development, 2021

 US$ 3,000.00

Mitogen Activated Protein Kinase Kinase Kinase 14 (NF Kappa Beta Inducing Kinase or Serine/Threonine Protein Kinase NIK or MAP3K14 or EC 2.7.11.25) - Drugs in Development, 2021 SUMMARY Mitogen Activat...

April 2021 30 pages

Mitogen Activated Protein Kinase Kinase Kinase Kinase 1 (Hematopoietic Progenitor Kinase or MAPK/ERK Kinase Kinase Kinase 1 or HPK1 or MAP4K1 or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Mitogen Activated Protein Kinase Kinase Kinase Kinase 1 (Hematopoietic Progenitor Kinase or MAPK/ERK Kinase Kinase Kinase 1 or HPK1 or MAP4K1 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Mitog...

April 2021 35 pages

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K or EC 2.7.12.2) - Drugs in Development, 2021

 US$ 3,000.00

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K or EC 2.7.12.2) - Drugs in Development, 2021 SUMMARY Mitogen Activated Protein Kinase Kinase (MEK or MAP2K or EC 2.7.12.2) - Drugs in Development,...

April 2021 35 pages

Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24) - Drugs in Development, 2021

 US$ 3,000.00

Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24) - Drugs in Development, 2021 SUMMARY Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24) - Drugs in Development, 2021 provides in depth anal...

April 2021 30 pages

Molluscum Contagiosum (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Molluscum Contagiosum (Infectious Disease) - Drugs in Development, 2021 SUMMARY Molluscum Contagiosum (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Molluscum Contagiosu...

April 2021 35 pages

Monoamine Oxidase (Adrenalin Oxidase or Epinephrine Oxidase or MAO or EC 1.4.3.4) - Drugs in Development, 2021

 US$ 3,000.00

Monoamine Oxidase (Adrenalin Oxidase or Epinephrine Oxidase or MAO or EC 1.4.3.4) - Drugs in Development, 2021 SUMMARY Monoamine Oxidase (Adrenalin Oxidase or Epinephrine Oxidase or MAO or EC 1.4.3.4)...

April 2021 30 pages

Monocarboxylate Transporter 1 (MCT 1 or Solute Carrier Family 16 Member 1 or SLC16A1) - Drugs in Development, 2021

 US$ 3,000.00

Monocarboxylate Transporter 1 (MCT 1 or Solute Carrier Family 16 Member 1 or SLC16A1) - Drugs in Development, 2021 SUMMARY Monocarboxylate Transporter 1 (MCT 1 or Solute Carrier Family 16 Member 1 or...

April 2021 30 pages

Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021 SUMMARY Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Motor Neuron...

April 2021 30 pages

Mouth and Dental Disorders (Mouth and Dental Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Mouth and Dental Disorders (Mouth and Dental Disorders) - Drugs in Development, 2021 SUMMARY Mouth and Dental Disorders (Mouth and Dental Disorders) - Drugs in Development, 2021 provides an overview o...

April 2021 30 pages

Movement Disorders (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Movement Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Movement Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Movement Disorders...

April 2021 40 pages

Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1) - Drugs in Development, 2021

 US$ 3,500.00

Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1) - Drugs in Development, 2021 SUMMARY Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OP...

April 2021 325 pages

Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) (Immunology) - Drugs in Development, 2021 SUMMARY Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) (Immunology) - Drugs in Development, 2021 pr...

April 2021 30 pages

Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) (Genetic Disorders) -...

April 2021 35 pages

Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) (Other Diseases) - Drugs in Development, 2021

 US$ 2,000.00

Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) (Other Diseases) - Drugs in Development, 2021 SUMMARY Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) (Other Diseases) - Drugs...

April 2021 35 pages

Muscarinic Acetylcholine Receptor M1 (CHRM1) - Drugs in Development, 2021

 US$ 3,000.00

Muscarinic Acetylcholine Receptor M1 (CHRM1) - Drugs in Development, 2021 SUMMARY Muscarinic Acetylcholine Receptor M1 (CHRM1) - Drugs in Development, 2021 provides in depth analysis on Muscarinic Ace...

April 2021 75 pages

Muscarinic Acetylcholine Receptor M3 (CHRM3) - Drugs in Development, 2021

 US$ 3,000.00

Muscarinic Acetylcholine Receptor M3 (CHRM3) - Drugs in Development, 2021 SUMMARY Muscarinic Acetylcholine Receptor M3 (CHRM3) - Drugs in Development, 2021 provides in depth analysis on Muscarinic Ace...

April 2021 65 pages

Muscle Atrophy (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Muscle Atrophy (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Muscle Atrophy (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Muscle Atrophy pipeline landscape. The r...

April 2021 30 pages

Muscle Injury (Musculoskeletal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Muscle Injury (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Muscle Injury (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Muscle Injury pipeline...

April 2021 30 pages

Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021 SUMMARY Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021 provides an overview of the Muscle I...

April 2021 75 pages

Muscle Spasm (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Muscle Spasm (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Muscle Spasm (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Muscle Spasm pipeline landscape. The report...

April 2021 30 pages

Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021 SUMMARY Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Muscle Spasticity pi...

April 2021 50 pages

Muscle Wasting Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Muscle Wasting Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Muscle Wasting Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the...

April 2021 30 pages

Musculoskeletal Pain (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Musculoskeletal Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Musculoskeletal Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Musculoskeleta...

April 2021 35 pages

Myalgia (Muscle Pain) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Myalgia (Muscle Pain) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Myalgia (Muscle Pain) (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Myalgia (Mus...

April 2021 30 pages

Mycobacterium avium Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Mycobacterium avium Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Mycobacterium avium Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the My...

April 2021 35 pages

Mycobacterium Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Mycobacterium Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Mycobacterium Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Mycobacterium...

April 2021 50 pages

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Drugs in Development, 2021

 US$ 3,000.00

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Drugs in Development, 2021 SUMMARY Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secreto...

April 2021 30 pages

Mycobacterium Tuberculosis Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Mycobacterium Tuberculosis Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Mycobacterium Tuberculosis Infections (Infectious Disease) - Drugs in Development, 2021 provides an over...

April 2021 40 pages

Mycobacterium tuberculosis Protein Ag85A - Drugs in Development, 2021

 US$ 3,000.00

Mycobacterium tuberculosis Protein Ag85A - Drugs in Development, 2021 SUMMARY Mycobacterium tuberculosis Protein Ag85A - Drugs in Development, 2021 provides in depth analysis on Mycobacterium tubercul...

April 2021 30 pages

Mycosis Fungoides (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Mycosis Fungoides (Oncology) - Drugs in Development, 2021 SUMMARY Mycosis Fungoides (Oncology) - Drugs in Development, 2021 provides an overview of the Mycosis Fungoides pipeline landscape. The report...

April 2021 65 pages

Myelofibrosis (Hematological Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Myelofibrosis (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Myelofibrosis (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the Myelofibrosis pipeline lan...

April 2021 125 pages

Myeloperoxidase (MPO or EC 1.11.2.2) - Drugs in Development, 2021

 US$ 3,000.00

Myeloperoxidase (MPO or EC 1.11.2.2) - Drugs in Development, 2021 SUMMARY Myeloperoxidase (MPO or EC 1.11.2.2) - Drugs in Development, 2021 provides in depth analysis on Myeloperoxidase (MPO or EC 1.1...

April 2021 30 pages

Myeloproliferative Disorders (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Myeloproliferative Disorders (Oncology) - Drugs in Development, 2021 SUMMARY Myeloproliferative Disorders (Oncology) - Drugs in Development, 2021 provides an overview of the Myeloproliferative Disorde...

April 2021 90 pages

Myopia (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Myopia (Ophthalmology) - Drugs in Development, 2021 SUMMARY Myopia (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Myopia pipeline landscape. The report provides comprehensive...

April 2021 35 pages

Myotonic Dystrophy (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Myotonic Dystrophy (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Myotonic Dystrophy (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Myotonic Dystrophy pipeline land...

April 2021 75 pages

Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Myxoid Liposarcoma pipeline landscape. The rep...

April 2021 35 pages

NAD+ ADP Ribosyltransferase (Poly Adenosine Diphosphate Ribose Polymerase or PARP or EC 2.4.2.30) - Drugs in Development, 2021

 US$ 3,000.00

NAD+ ADP Ribosyltransferase (Poly Adenosine Diphosphate Ribose Polymerase or PARP or EC 2.4.2.30) - Drugs in Development, 2021 SUMMARY NAD+ ADP Ribosyltransferase (Poly Adenosine Diphosphate Ribose Po...

April 2021 65 pages

NADH Ubiquinone Oxidoreductase Chain 1 (NADH Dehydrogenase Subunit 1 or MT-ND1 or EC 7.1.1.2) - Drugs in Development, 2021

 US$ 3,000.00

NADH Ubiquinone Oxidoreductase Chain 1 (NADH Dehydrogenase Subunit 1 or MT-ND1 or EC 7.1.1.2) - Drugs in Development, 2021 SUMMARY NADH Ubiquinone Oxidoreductase Chain 1 (NADH Dehydrogenase Subunit 1...

April 2021 30 pages

NADPH Oxidase (NOX or EC 1.6.3.1) - Drugs in Development, 2021

 US$ 3,000.00

NADPH Oxidase (NOX or EC 1.6.3.1) - Drugs in Development, 2021 SUMMARY NADPH Oxidase (NOX or EC 1.6.3.1) - Drugs in Development, 2021 provides in depth analysis on NADPH Oxidase (NOX or EC 1.6.3.1) ta...

April 2021 45 pages

Na+/K+ Exchanging ATPase (Sodium Potassium ATPase or Sodium Potassium Pump or EC 7.2.2.13) - Drugs in Development, 2021

 US$ 3,000.00

Na+/K+ Exchanging ATPase (Sodium Potassium ATPase or Sodium Potassium Pump or EC 7.2.2.13) - Drugs in Development, 2021 SUMMARY Na+/K+ Exchanging ATPase (Sodium Potassium ATPase or Sodium Potassium Pu...

April 2021 35 pages

Natural Killer Cell Lymphomas (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Natural Killer Cell Lymphomas (Oncology) - Drugs in Development, 2021 SUMMARY Natural Killer Cell Lymphomas (Oncology) - Drugs in Development, 2021 provides an overview of the Natural Killer Cell Lymp...

April 2021 100 pages

Nausea (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Nausea (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Nausea (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Nausea pipeline landscape. The report provides compreh...

April 2021 40 pages

Necrotizing Enterocolitis (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Necrotizing Enterocolitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Necrotizing Enterocolitis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Necrotizing Ente...

April 2021 40 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1